Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. infection particularly
Show results for
Products
Software

Companies

News
Articles

Refine by
Date

  • Older

Infection Particularly Articles & Analysis

8 news found

Advancing Tuberculosis Treatment: The Role of flexiVent In Evaluating Bacteriophage Therapy

Advancing Tuberculosis Treatment: The Role of flexiVent In Evaluating Bacteriophage Therapy

The rise of antibiotic-resistant bacteria has driven renewed interest in alternative treatments, including phage therapy. A recent study by Yang, F., et al (2024) explores the potential of bacteriophage therapy for treating multi-drug resistant Mycobacterium tuberculosis (Mtb) infections using humanized mouse models. This study highlights the efficacy of phage DS6A in reducing Mtb load ...

BySCIREQ - an emka TECHNOLOGIES Company


TriMedika Wins Innovate UK Women in Innovation Awards

TriMedika Wins Innovate UK Women in Innovation Awards

” “The funding from this award will build upon the professional clinically-approved ‘non-contact’ TRITEMP thermometer, which is already saving hospitals millions of pounds per year and helping eliminate hospital infections in hospitals worldwide. We are now developing a device that captures patient temperature and patient detail and automatically uploads ...

ByTriMedika


The transformation of precision medicine in infectious disease

The transformation of precision medicine in infectious disease

Before Alexander Fleming discovered penicillin, another more selective antibacterial agent rose to popularity in the early 1900s: bacteriophage. In 1917, microbiologist Felix d’Herelle was tasked with identifying the cause of a dysentery outbreak impacting French troops. From his research, he noticed that Shigella bacteria was the primary culprit of this affliction. He then discovered an ...

ByLocus Biosciences, Inc.


Eg Technology And Health Enterprise East Announce Winners Of The 2021 Innovation Voucher Award

Eg Technology And Health Enterprise East Announce Winners Of The 2021 Innovation Voucher Award

Also in receipt of the award, are Mr Andrew Hindmarch and Dr Gareth Corbett who have designed a solution for aerosol reduction to mitigate the risk of cross-infection from aerosol-generating procedures. This is particularly important during a pandemic and when operating on patients with other infectious diseases, that can be transmitted by aerosolisation. ...

Byeg Technology Ltd


Italian Exhibition Group chooses Gbac Star for its international sanification standard

Italian Exhibition Group chooses Gbac Star for its international sanification standard

Founded on great experience built up at international level in the cleaning of environments in which pathogens spread in the past (from influence to infective diseases resistant to antibiotics), the GBAC STAR™ program will enable to establish and maintain control based on the training and accountability of IEG´s management and employees on the cleaning and ...

ByItalian Exhibition Group S.p.A (IEG)


CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections

CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections

This vaccine would also have the potential to prevent infections in newborns by stimulating maternal immunity in pregnant women, an issue of critical importance particularly in low-to-middle income countries around the ...

ByVaxdyn, S. L.


Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ

Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ

Food and Drug Administration (FDA) approved microbroth dilution susceptibility plates, expanding testing options for microbiology laboratories, and providing the quantitative susceptibility results clinicians need to make treatment decisions for serious Gram-negative infections. Cefiderocol and imipenem/relebactam, represent two of the latest treatment options for complicated ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Fungal Pathogens in Homes and Everyday Environments can Pose a Health Threat

Fungal Pathogens in Homes and Everyday Environments can Pose a Health Threat

Some types of fungi, including some found in indoor environments suffering from mold growth, can cause serious infections in some people. This is particularly true in people with a weakened immune system. ...

ByCochrane & Associates, LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT